Aviz în curs de adoptare (updated on 25/09/2023)
Referințe:
ECO/623-EESCRapporteur:
Co-rapporteur:
Sesiune plenară:
582 -
Oct 25, 2023 Oct 26, 2023
Opinions
Pages
Displaying 11 - 20 of 2886
Aviz în curs de adoptare (updated on 25/09/2023)
Referințe:
NAT/913-EESCRapporteur:
EESC exploratory opinion NAT/913 - Towards the Common Agricultural Policy (CAP) post-2027: for an agricultural sector that meets economic, social and environmental needs
Aviz în curs de adoptare (updated on 25/09/2023)
Referințe:
CCMI/212-EESCRapporteur:
Lech PILAWSKI (Employers - GR I/Poland), Lech PILAWSKI (Employers - GR I/Poland) (Employers - GR I / Poland)
Co-rapporteur:
Thomas STUDENT (Germany)
Sesiune plenară:
583 -
Dec 13, 2023 Dec 14, 2023
The Covid 19-pandemic has drawn attention to the role of the pharmaceutical industry and to production, availability and affordability of medicines and medicinal products on the European market.
Dependency on critical ingredients, such as active pharmaceutical ingredients (APIs), became obvious when China and India limited exports. According to current data, up to 80% of APIs used in Europe and about 40% of finished medicines sold in Europe come from China or India. The European Union's increasing dependence on API supplies has led to a partial loss of capability to manufacture active substances independently, which poses a potential threat to public health in the countries of the European Union.
Aviz în curs de adoptare (updated on 25/09/2023)
Referințe:
SOC/769-EESCRapporteur:
Sesiune plenară:
582 -
Oct 25, 2023 Oct 26, 2023
Aviz în curs de adoptare (updated on 22/09/2023)
Referințe:
INT/1023-EESC-2023-01711Rapporteur:
Co-rapporteur:
Corruption and the lack of rule of law undermine the mutual trust that is underpinning the internal market. This opinion should contribute to bringing attention to how challenges to the rule of law affect the internal market and in particular public procurement.
Aviz în curs de adoptare (updated on 22/09/2023)
Referințe:
INT/1041-EESC-EESC-2023-03705-00-00-AC-TRARapporteur:
Panagiotis GKOFAS (Diversity Europe - GR III/Greece), Alena MASTANTUONO (Employers - GR I/Czech Republic), Angelo PAGLIARA (Workers - GR II/Italy)
EU rules on late payments have triggered a reduction in payment delays. However, still more than 60% of businesses in the EU are not paid on time and small and medium-sized enterprises are most affected. The initiative will provide relief to SMEs by revising existing EU payment rules based on available and upcoming evidence to promote a definitive shift towards a culture of “prompt payment".
Aviz în curs de adoptare (updated on 22/09/2023)
Referințe:
CCMI/219-EESCRapporteur:
Co-rapporteur:
Antonello PEZZINI (Italy)
Aviz în curs de adoptare (updated on 22/09/2023)
Referințe:
INT/1030-EESC-2023-01968Referral:
COM(2023) 190 final COM(2023) 191 final 2023/0125 NLECOM(2023) 191 final 2023/0125 NLECOM(2023) 192 final 2023/0132 CODCOM(2023) 192 final 2023/0132 CODCOM(2023) 193 final 2023/0131 CODCOM(2023) 193 final 2023/0131 CODRapporteur:
Sesiune plenară:
582 -
Oct 25, 2023 Oct 26, 2023
The Commission is proposing an ambitious revision of the EU pharmaceutical legislation (including a Directive and a Regulation), in order to, inter alia, create a Single Market for medicines, ensure an innovation-friendly framework for research and production and reduce the administrative burden.
Aviz în curs de adoptare (updated on 21/09/2023)
Referințe:
NAT/905-EESCReferral:
COM(2023) 414 final 2023/0227 CODCOM(2023) 414 final 2023/0227 CODCOM(2023) 415 final 2023/0228 CODCOM(2023) 415 final 2023/0228 CODRapporteur:
EESC opinion on Seeds and other plant and forest reproductive material.
Aviz în curs de adoptare (updated on 19/09/2023)
Referințe:
ECO/629-EESC-04143Rapporteur:
Administrateur: Juri SOOSAAR / Assistante: Graziella DILKINSKA
Contact: E-mail